Le 6 février/February 2019
Following the completion of the Arrangement as set out in the Company's management information circular (the "Circular") dated December 11, 2018 and approved by the Company's security holders at the Company's special meeting held on January 15, 2019 (the "Special Meeting"), the common shares of MPX Bioceutical Corporation will be delisted at the market close today February 6, 2019.
As part of the Arrangement, MPX Bioceutical Corporation, amalgamated with 1183271 B.C. Unlimited Liability Company, a wholly owned subsidiary of iAnthus Capital Holdings, Inc. (CSE: IAN) ("iAnthus") created for the purposes of the Arrangement.
|Date:||Market Close/Clôture du marchés le 6 février/February 2019|
If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com
Pour toute question, pour obtenir de l’information supplémentaire veuillez communiquer avec le service des inscriptions au 416 367-7340 ou par courriel à l’adresse: Listings@thecse.com